Ani pharmaceuticals, inc. prices upsized $275.0 million convertible senior notes offering

Princeton, n.j., aug. 07, 2024 (globe newswire) -- ani pharmaceuticals, inc. (ani or the company) (nasdaq: anip) today announced the pricing of its offering of $275,000,000 aggregate principal amount of 2.25% convertible senior notes due 2029 (the “notes”) in a private offering to qualified institutional buyers pursuant to rule 144a under the securities act of 1933, as amended (the “securities act”). the offering size was increased from the previously announced offering size of $250,000,000 aggregate principal amount of notes. the issuance and sale of the notes are scheduled to settle on august 13, 2024, subject to customary closing conditions. ani also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $41,250,000 principal amount of notes.
ANIP Ratings Summary
ANIP Quant Ranking